Lutetium-177 With RT Prolongs Survival in Prostate Cancer – Medscape

  1. Lutetium-177 With RT Prolongs Survival in Prostate Cancer  Medscape
  2. Practice-Influencing Results in Oligometastatic Prostate Cancer  MedPage Today
  3. Adding PSMA-targeting radioligand therapy to stereotactic body radiotherapy more than doubled…

Continue Reading